In cancer patients treated with TZ, 21.9% developed HF; regular LVEF assessments and antihypertensive medications like ARBs and ACE inhibitors are crucial for managing cardiotoxicity and improving outcomes. The gene discussed is ACE; the disease is hydrops fetalis.